Dynorphins, natural opioid peptides in the brain, can directly porate cell membranes by forming large nanoscale pores — a non-receptor mechanism that may explain their known neurotoxic and pain-causing effects.
~2.7 nm membrane poresDynorphins form giant, unstructured, non-ion-selective pores in cell membranes — large enough to disrupt normal cellular function and cause neuronal death
What the researchers found
Using fluorescence correlation spectroscopy and patch-clamp electrophysiology, the researchers demonstrated that dynorphins accumulate in the plasma membrane and induce transient increases in ionic conductance consistent with the formation of giant (~2.7 nm diameter) unstructured, non-ion-selective membrane pores.
Critically, the potency of different dynorphin variants to porate membranes correlated with their known pathogenic effects in cellular and animal models of neurodegeneration. This establishes membrane poration as a probable mechanism for dynorphin-mediated pathological signal transduction, neuronal excitation, and cell death.
Why it matters
Dynorphin levels are elevated in many neurological conditions including traumatic brain injury, epilepsy, and neurodegenerative diseases. Understanding that these peptides can directly damage cells by porating their membranes — bypassing traditional receptor pathways — opens an entirely new target for therapeutic intervention in these devastating conditions.
How the study worked
The study used two complementary biophysical techniques: fluorescence correlation spectroscopy to track dynorphin accumulation in the plasma membrane, and patch-clamp electrophysiology to measure changes in ionic conductance (electrical current across the membrane) when dynorphins were applied. Multiple dynorphin variants and other opioid peptides were compared to establish structure-activity relationships for membrane poration.
What this study cannot tell us
The study was conducted primarily in cultured cells and model systems, not in living organisms. The exact in vivo relevance of membrane poration at physiological dynorphin concentrations is not established. The long-term consequences of repeated membrane poration events were not examined. The 2.7 nm pore diameter is an estimate based on conductance measurements.
How to read the evidence
This is a preclinical mechanistic study using advanced biophysical techniques in cell models. It provides strong evidence for a novel mechanism of action but has not been validated in vivo in living organisms.
When this study was published
Published in 2015, this study identified a novel mechanism of neuropeptide toxicity that has since informed research on dynorphin-related neurodegeneration and non-receptor peptide effects.
The bigger picture
This discovery challenges the traditional view that neuropeptides act exclusively through receptors. If endogenous peptides can directly disrupt cell membranes, it adds a new dimension to our understanding of how peptides function in health and disease. It also suggests that therapeutic strategies for neurodegeneration may need to address membrane-level damage, not just receptor-mediated signaling.
Questions still open
- Could drugs that prevent dynorphin membrane insertion protect against neurodegeneration in conditions with elevated dynorphin levels?
- Do other endogenous neuropeptides also have membrane-porating activity, or is this unique to dynorphins?
- At what concentration threshold do dynorphins shift from normal receptor-mediated signaling to pathological membrane poration?
Common questions
What are dynorphins and why are they important?
How could this discovery lead to new treatments?
Read the original research
Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction.
Cell death & disease, 6(3), e1683
Citation
Maximyuk, O; Khmyz, V; Lindskog, C-J; Vukojević, V; Ivanova, T; Bazov, I; Hauser, K F; Bakalkin, G; Krishtal, O. (2015). Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction.. Cell death & disease, 6(3), e1683. https://doi.org/10.1038/cddis.2015.39